Logo
x

Search

Subscribe Now

Allergan

Allergan and AbbVie Report the Results for TrenibotulinumtoxinE (BoNT/E) In P-III Trials for the Treatment of Glabellar Lines

Allergan and AbbVie Report the Results for TrenibotulinumtoxinE (BoNT/E) In P-III Trials for the Treatment of Glabellar Lines

  • October 25, 2023
Allergan Reports Results of Vuity in P-III (VIRGO) Trial for the Treatment of Presbyopia or Age-Related Blurry Near Vision

Allergan Reports Results of Vuity in P-III (VIRGO) Trial for the Treatment of Presbyopia or Age-Related Blurry Near Vision

  • April 6, 2022
Allergan's Vuity Receives the US FDA's Approval as First Eye Drop for the Treatment of Presbyopia

Allergan's Vuity Receives the US FDA's Approval as First Eye Drop for the Treatment of Presbyopia

  • October 29, 2021
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

  • February 11, 2021
Insights+: The US FDA New Drug Approvals in March and April 2020

Insights+: The US FDA New Drug Approvals in March and April 2020

  • May 15, 2020
Top 20 BioPharma Companies based on 2019 Total Revenue

Top 20 BioPharma Companies based on 2019 Total Revenue

  • April 24, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.